Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-14

Clinical Trial Update: Shenbai Granules for Preventing Recurrence of Low-Risk Colorectal Adenomas [NA]

View source ↗

Summary

The document reports a clinical trial evaluating Shenbai Granules for preventing recurrence of low-risk colorectal adenomas, with the study not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Shenbai Granules

Snippet

Sponsor: Jiangsu Famous Medical Technology Co., Ltd. | Conditions: Colorectal Adenoma, TCM | NA | Status: NOT_YET_RECRUITING